AMLo Biosciences
UK-based medical device company that specialises in the early detection of skin cancers
AMLo Biosciences has raised €2.9M across 1 funding round from 5 investors, most recently a round in Apr 2022. Based in London, UK; active in Healthtech. Data as of 28 Oct 2026.
London, UKwww.amlo-biosciences.com ↗
Total raised
€2.9M
€2,933,324
Funding rounds
1
Investors
5
distinct backers
Active since
2022-04
latest 2022-04
Funding by year
EUR raised per yearAMLo Biosciences — funding by year — interactive chart.
Data table
| AMLo Biosciences — funding by year | |
|---|---|
| 2022 | €2.9M |
Signals
High confidenceRaise-next likelihood6
base rate 30% for Other
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-04-21 | Other | €2.9M | Ascension’s Life Fund,Conduit’s EIS Impact Fund,Esperante,Future Planet Capital’s BIF Opportunities Fund,Northstar Ventures | View deal → |